|
|
|
Volumn 29, Issue 2, 2014, Pages 214-224
|
|
[Treatment of tardive syndromes];Atardív szindrómák kezelési lehetőségei
a a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
AMANTADINE;
BOTULINUM TOXIN;
CENTRAL NERVOUS SYSTEM AGENTS;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLONAZEPAM;
DOPAMINE RECEPTOR BLOCKING AGENT;
ETIRACETAM;
NEUROLEPTIC AGENT;
NOOTROPIC AGENT;
PIRACETAM;
PROPRANOLOL;
TETRABENAZINE;
ANALOGS AND DERIVATIVES;
BRAIN DEPTH STIMULATION;
CLINICAL TRIAL (TOPIC);
GINKGO BILOBA;
HUMAN;
MOVEMENT DISORDERS;
PATHOPHYSIOLOGY;
PRIMARY PREVENTION;
PROCEDURES;
SYNDROME;
AMANTADINE;
ANTIPSYCHOTIC AGENTS;
BOTULINUM TOXINS;
CENTRAL NERVOUS SYSTEM AGENTS;
CHOLINERGIC ANTAGONISTS;
CLINICAL TRIALS AS TOPIC;
CLONAZEPAM;
DEEP BRAIN STIMULATION;
DOPAMINE ANTAGONISTS;
GINKGO BILOBA;
HUMANS;
MOVEMENT DISORDERS;
NOOTROPIC AGENTS;
PIRACETAM;
PRIMARY PREVENTION;
PROPRANOLOL;
SYNDROME;
TETRABENAZINE;
VITAMIN E;
|
|
EID: 84907982841
PISSN: 02377896
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|